CRDL

Cardiol Therapeutics
$1.16
−$0.03 (−2.12%)Jul 27, 2026
1.0PoorMoatMint rating

MoatMint rates Cardiol Therapeutics (CRDL) 1.0 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.3 out of 10.

Key metrics

The numbers that frame CRDL today
Market cap
$129.21M
P/E (TTM)
-4.8
EV / FCF
-6.1
ROIC
997.9%
Div yield
0%
Debt / equity
0.0
52wk Low
$0.88
52wk High
$1.71

CRDL stock rating

How CRDL scores on quality, value, growth, momentum and financial health
1.0out of 10
Low overallNeutral business, expensive priceTop 90% of ~5,000 US stocks
QualityPoor0.3/10
GrowthNeutral5.3/10
MomentumFair3.0/10
ValuePoor1.6/10
Financial HealthFair2.9/10

Growth

Revenue and earnings trend for CRDL
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CRDL
Is Cardiol Therapeutics a good buy?
No. Cardiol Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Cardiol Therapeutics is selling at a very high price.
What is the market capitalization of CRDL?
Cardiol Therapeutics's market capitalization is $129.21M.
What is the P/E ratio for CRDL stock?
Cardiol Therapeutics's current P/E ratio is -4.8.
What is the 52-week high for CRDL stock?
The 52-week high for Cardiol Therapeutics is $1.71. The current close of $1.16 is 32.5% below that high.
What is the 52-week low for CRDL stock?
The 52-week low for Cardiol Therapeutics is $0.88. The current close of $1.16 is 31.3% above that low.
Does CRDL stock pay dividends?
Cardiol Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRDL?
Cardiol Therapeutics's Debt / Equity ratio is 0.01.